Survival Outcomes and Impact of Targeted PAH Therapy in Portopulmonary Hypertension in the PVRI GoDeep Meta-Registry.
Jose A, Yogeswaran A, Fuenderich M, Kiely D, Sweatt AJ, Zamanian RT, Hassoun PM, Mouawad A, Balasubramanian A, Wilkins M, Lawrie A, Howard L, Sahay S, Olschewski H, Kovacs G, Saleh K, Sabbour H, Eichstaedt CA, Grünig E, Giannakoulas G, Arvanitaki A, Sirenko Y, Torbas O, Cajigas H, Frantz R, Scelsi L, Ghio S, Majeed RW, Wilhelm J, Ghofrani HA, Grimminger F, Tello K, Elwing J, Seeger W; PVRI‐GoDeep‐Consortium.
Jose A, et al.
Pulm Circ. 2025 Jul 8;15(3):e70121. doi: 10.1002/pul2.70121. eCollection 2025 Jul.
Pulm Circ. 2025.
PMID: 40636151
Free PMC article.